Ligand id: 9638

Name: ozoralizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9369 ozoralizumab
ATN-103 | PF-5230896
Ozoralizumab is a trivalent albumin-binding nanobody that binds to and neutralises circulating TNFα. This biologic agent is being investigated for anti-inflammatory potential. The peptide sequence for ozoralizumab submitted in its WHO INN record is identical to SEQ ID NO: 96 (TNF30) in patent US8703131 [1], and identifies the albumin nanobody as ALB8. The patent claims a trivalent construct of TNF30-linker-ALB8-linker-TNF30.
Database Links
Specialist databases
IMGT/mAb-DB 382
Other databases
GtoPdb PubChem SID 340590268
Search PubMed clinical trials ozoralizumab
Search PubMed titles ozoralizumab
Search PubMed titles/abstracts ozoralizumab